Forced magnetic reconnection due to transient resonant magnetic perturbations in flowing tokamak plasmas
Physics of Plasmas · 01.06.2026 · 33 (6)
DOI: 10.1063/5.0324197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physics of Plasmas, online erschienen am 23.06.2026. Verfasst von Y. Lin und 1 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Gefördert von: U.S. Department of Energy.
Abstract (Originalsprache)
Asymptotic matching techniques are used to investigate the linear drift-magnetohydrodynamical response of a flowing tokamak plasma to a transient resonant magnetic perturbation (RMP). It is demonstrated that knowledge of the solution of the “Taylor problem,” in which the RMP is suddenly switched on, and subsequently held steady, is sufficient to solve for the response of a transient RMP of arbitrary time dependence. The reconnected magnetic flux driven by the RMP is calculated as a function of time via two alternative methods. The first solution method, which is exact, but time-consuming, involves the numerical evaluation of a contour integral in Laplace transform space. The second solution method, which is approximate, but much less time-consuming, involves closed-form analytic solutions in one of seven different response regimes. The results of the two solution methods are compared.
Förderung
- U.S. Department of Energy
Zitieren
APA
Lin, Y., & Fitzpatrick, R. (2026). Forced magnetic reconnection due to transient resonant magnetic perturbations in flowing tokamak plasmas. Physics of Plasmas, 33(6). https://doi.org/10.1063/5.0324197
Vancouver
Lin Y, Fitzpatrick R. Forced magnetic reconnection due to transient resonant magnetic perturbations in flowing tokamak plasmas. Physics of Plasmas. 2026;33(6). doi:10.1063/5.0324197
BibTeX
@article{Lin2026,
author = {Lin, Y. and Fitzpatrick, R.},
title = {Forced magnetic reconnection due to transient resonant magnetic perturbations in flowing tokamak plasmas},
journal = {Physics of Plasmas},
year = {2026},
volume = {33},
number = {6},
doi = {10.1063/5.0324197}
}
EUVIMED